Numerical Targets under the 10th Mid-Term Management Plan
First written in FY2021. 3 of 10 entries say "Advanced", first in FY2022-Q1. Latest entry: FY2026.
King Jim moved to the "Worse" side of this theme in 2026, 2 years after the typical company in this theme (2024).
4 other companies' latest entry also says "Softened".
- FY2026SoftenedAnnual report
「In light of uncompleted M&A transactions, delays in launching the services business, changes in the business environment and the impact of foreign exchange fluctuations exceeding expectations, among other factors, we revised the targets for the fiscal year ending June 2027, the final year of the 11th Medium-Term Management Plan, to net sales of ¥42.0 billion, ordinary income of ¥1.62 billion, an ordinary income margin of 3.9%, and ROE of 4.0%.」
The targets for the final year of the 11th Medium-Term Management Plan were substantially revised downward from the original targets of net sales of ¥52.0 billion, ordinary income of ¥2.8 billion, an ordinary income margin of 5.4%, and ROE of 8.0%. - FY2025AdvancedAnnual report
「In the first fiscal year, the current consolidated fiscal year, initiatives progressed broadly as planned and the foundation for the second year was established. Net sales were ¥39,639.5 million, 3.3% below the plan of ¥41.0 billion. Meanwhile, ordinary income was ¥836.24 million, 19.5% above the plan of ¥700 million, and ROE was 1.8%.」
Disclosed the results for the first year of the 11th Medium-Term Management Plan and the establishment of a foundation for the second year. Net sales fell short of the first-year plan, while ordinary income exceeded the plan. - FY2024-Q3RestatedAnnual report
「Against this backdrop, we continued implementing initiatives to achieve the targets of the 10th Medium-Term Management Plan (fiscal years ending June 2022 to June 2024).」
The company continues initiatives to achieve the targets of the 10th Medium-Term Management Plan. - FY2024-Q1RestatedAnnual report
「Against this backdrop, we continued implementing initiatives to achieve the targets of the 10th Medium-Term Management Plan (fiscal years ending June 2022 to June 2024).」
The company continues initiatives to achieve the targets of the 10th Medium-Term Management Plan. - FY2023SoftenedAnnual report
「However, in light of changes in demand exceeding expectations and foreign exchange fluctuations, among other factors, we revised the targets for the fiscal year ending June 2024, the final year of the 10th Medium-Term Management Plan, to net sales of ¥42.0 billion, ordinary income of ¥900 million, an ordinary income margin of 2.1%, and ROE of 2.4%.」
For the fiscal year ending June 2024, the company revised downward the original targets of the 10th Medium-Term Management Plan: net sales of ¥48.0 billion, ordinary income of ¥3.4 billion, an ordinary income margin of 7.0%, and ROE of 9.0%. - FY2023-Q3RestatedAnnual report
「Against this backdrop, we continued implementing initiatives to achieve the targets of the 10th Medium-Term Management Plan (fiscal years ending June 2022 to June 2024).」
The company continues initiatives to achieve the targets of the 10th Medium-Term Management Plan. - FY2022First-year results disclosedAnnual report
「In the first fiscal year, the current consolidated fiscal year, net sales were ¥36.6 billion, ordinary income was ¥1.3 billion, the ordinary income margin was 3.7%, and ROE was 3.3%.」
Disclosed net sales, ordinary income, ordinary income margin and ROE as the results for the first fiscal year of the 10th Medium-Term Management Plan. - FY2022-Q2AdvancedAnnual report
「Against this backdrop, we will continue implementing measures to achieve the targets of the 10th Medium-Term Management Plan (fiscal years ending June 2022 to June 2024) while protecting the safety of our customers and employees through ongoing infection prevention measures.」
The company continues to advance initiatives to achieve the targets of the 10th Medium-Term Management Plan following the start of the plan. The conversion of Life on Products into a subsidiary is also a specific measure targeting growth areas. - FY2022-Q1AdvancedAnnual report
「While protecting the safety of customers and employees through ongoing infection prevention measures, the company began initiatives to achieve the targets of the 10th Medium-Term Management Plan (fiscal years ending June 2022 to June 2024).」
Explicitly stated that initiatives to achieve the targets of the 10th Medium-Term Management Plan, whose final fiscal year is the fiscal year ending June 2024, had begun. - FY2021First statedAnnual report
「Under the 10th Medium-Term Management Plan, whose final fiscal year is the fiscal year ending June 2024, our Group has set targets of net sales of ¥48.0 billion, ordinary income of ¥3.4 billion, an ordinary income margin of 7.0%, and return on equity (ROE) of 9.0%.」
Disclosed for the first time the numerical targets for net sales, ordinary income, ordinary income margin and ROE under the 10th Medium-Term Management Plan, whose final fiscal year is the fiscal year ending June 2024.